FDA inspection

Joslin Diabetes Center Committee on Human Studies: FDA inspection ending Nov 27, 2018

FDA inspection 1082467 · No Action Indicated (NAI) · Boston, MA

Key facts

Inspection ID 1082467
Firm Joslin Diabetes Center Committee on Human Studies
FEI number 1283624
Address 1 Joslin Pl Ste 760
City Boston
State MA
ZIP 02215
Country United States
Fiscal year 2019
Inspection end date Nov 27, 2018
Classification No Action Indicated (NAI)
Project area Bioresearch Monitoring
Product type Devices

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections